Secondary
infection, febrile illness
INFECTION, FEBRILE ILLNESS

To estimate the relative and absolute rate reduction (derived from the same model) of symptomatic culture-confirmed S. Typhi infection among participants in vaccine clusters compared to participants in non-vaccine clusters (overall effect)To estimate the relative and absolute rate reduction of symptomatic culture-confirmed To estimate the relative and absolute rate reduction of febrile illness resulting in healthcare visits in vaccinated participants in vaccine clusters compared to unvaccinated participants in non-vaccine clustersTo describe safety outcomes associated with TyphiBEV® vaccination within the study population